Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitlePhase 1 dose escalation trial of ilorasertib, a dual Aurora/VEGF receptor kinase inhibitor, in patients with hematologic malignancies.AuthorsGarcia-Manero, Guillermo; Tibes, Raoul; Kadia, Tapan; Kantarjian, Hagop; Arellano, Martha; Knight, Emily; Xiong, Hao; Qin, Qin; Munasinghe, Wijith; Roberts-Rapp, Lisa; Ansell, Peter; Albert, Daniel; Oliver, Brian; McKee, Mark; Ricker, Justin; Khoury, HannaPublicationInvestigational New Drugs, 2015, Vol 33, Issue 4, p870ISSN0167-6997Publication typeArticleDOI10.1007/s10637-015-0242-6